Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-01-08
2000-03-21
MacMillan, Keith D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514408, 514283, 514423, 514549, 514449, 435108, 424450, 424490, 5483351, A61K 3140
Patent
active
060403306
ABSTRACT:
A pharmaceutical formulation of a taxane antineoplastic agent, particularly paclitaxel or docetaxel or a pharmaceutically acceptable salt thereof, and N-methylpyrrolidin-2-one (NMP). The formulation may include other excipients and/or diluents, and is suitable for administration to patients with cancer.
REFERENCES:
patent: 5399363 (1995-03-01), Liversidge et al.
patent: 5498421 (1996-03-01), Grinstaff et al.
patent: 5614549 (1997-03-01), Greenwald et al.
patent: 5859023 (1999-01-01), Hausheer et al.
Hausheer Fredrick H.
Murali Dhanabalan
Seetharamulu Peddaiahgari
BioNumerik Pharmaceuticals, Inc.
Dodd Thomas J.
Kim Vickie
MacMillan Keith D.
LandOfFree
Pharmaceutical formulations of taxanes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical formulations of taxanes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulations of taxanes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-730665